Synthesis and anti-HIV evaluation of novel 1,2,4-triazole derivatives as potential non-nucleoside HIV-1 reverse transcriptase inhibitors

Letters in Drug Design and Discovery

Volumn 10, Issue 1, 2013, Pages 27-34

  Li, Zhenyu ^a   Cao, Yuan ^a   Zhan, Peng ^a   Pannecouque, Christophe ^b   Balzarini, Jan ^b   De Clercq, Erik ^b   Liu, Xinyong ^a  

^a SHANDONG UNIVERSITY   (China)

^b REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

AIDS, NNRTIs; Anti HIV 1 activity; HIV 1; Synthesis; Triazoles

Indexed keywords

1,2,4 TRIAZOLE DERIVATIVE; 3 [[4 (3,4 DIMETHOXYBENZYLIDENEAMINO) 5 (FURAN 2 YL) 4H 1,2,4 TRIAZOL 3 YLTHIO]METHYL]BENZONITRILE; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG SCREENING; DRUG SYNTHESIS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; NONHUMAN; PRIORITY JOURNAL; WILD TYPE;

EID: 84875412177     PISSN: 15701808     EISSN: 1875628X     Source Type: Journal    
DOI: 10.2174/157018013804142429     Document Type: Article

References (19)

1. La Regina, G.; Coluccia, A.; Brancale, A.; Piscitelli, F.; Gatti, V.; Maga, G.; Samuele, A.; Pannecouque, C.; Schols, D.; Balzarini, J.; Novellino, E.; Silvestri, R. Indolylarylsulfones as HIV-1 nonnucleoside reverse transcriptase inhibitors: new cyclic substituents at indole-2-carboxamide. J. Med. Chem., 2011, 54, 1587-1598.
2. Li, D.; Zhan, P.; De Clercq, E.; Liu, X. Strategies for the Design of HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors: Lessons from the Development of Seven Representative Paradigms. J. Med. Chem., 2012, 55, 3595-613..
3. Zhan, P.; Liu, X.; Fang, Z.; Pannecouque, C.; De Clercq, E. 1,2,3- Selenadiazole thioacetanilides: synthesis and anti-HIV activity evaluation. Bioorg. Med. Chem., 2009, 17, 6374-6379.
4. Wang, X.; Zhang, J.; Huang, Y.; Wang, R.; Zhang, L.; Qiao, K.; Li, L.; Liu, C.; Ouyang, Y.; Xu, W.; Zhang, Z.; Shao, Y.; Jiang, S.; Ma, L.; Liu, J. Design, Synthesis, and Biological Evaluation of 1- [(2-Benzyloxyl/alkoxyl) methyl]-5-halo-6-aryluracils as Potent HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors with an Improved Drug Resistance Profile. J. Med. Chem., 2012, 55, 2242-2250.
5. Zhan, P.; Liu, X.; Zhu, J.; Fang, Z.; Li, Z.; Pannecouque, C.; Clercq, E. D. Synthesis and biological evaluation of imidazole thioacetanilides as novel non-nucleoside HIV-1 reverse transcriptase inhibitors. Bioorg. Med. Chem., 2009, 17, 5775-5781.
6. Zhan, P.; Liu, X.; Fang, Z.; Li, Z.; Pannecouque, C.; De Clercq, E. Synthesis and anti-HIV activity evaluation of 2-(4-(naphthalen-2- yl)-1,2,3-thiadiazol-5-ylthio)-N-acetamides as novel nonnucleoside HIV-1 reverse transcriptase inhibitors. Eur. J. Med. Chem., 2009, 44, 4648-4653.
7. Kirschberg, T. A.; Balakrishnan, M.; Huang, W.; Hluhanich, R.; Kutty, N.; Liclican, A. C.; McColl, D. J.; Squires, N. H.; Lansdon, E. B. Triazole derivatives as non-nucleoside inhibitors of HIV-1 reverse transcriptase- structure-activity relationships and crystallographic analysis. Bioorg. Med. Chem. Lett., 2008, 18, 1131-1134.
8. Bu, H. Z.; Pool, W. F.; Wu, E. Y.; Raber, S. R.; Amantea, M. A.; Shetty, B. V. Metabolism and excretion of capravirine, a new nonnucleoside reverse transcriptase inhibitor, alone and in combination with ritonavir in healthy volunteers. Drug Metab. Dispos., 2004, 32, 689-698.
9. Loksha, Y. M.; el-Barbary, A. A.; el-Badawi, M. A.; Nielsen, C.; Pedersen, E. B. Synthesis of 2-(aminocarbonylmethylthio)-1Himidazoles as novel Capravirine analogues. Bioorg. Med. Chem., 2005, 13, 4209-4220.
10. Gewurz, B. E.; Jacobs, M.; Proper, J. A.; Dahl, T. A.; Fujiwara, T.; Dezube, B. J. Capravirine, a nonnucleoside reverse-transcriptase inhibitor in patients infected with HIV-1: a phase 1 study. J. Infect. Dis., 2004, 190, 1957-1961.
11. Zhang, Z.; Xu, W.; Koh, Y. H.; Shim, J. H.; Girardet, J. L.; Yeh, L. T.; Hamatake, R. K.; Hong, Z. A novel nonnucleoside analogue that inhibits human immunodeficiency virus type 1 isolates resistant to current nonnucleoside reverse transcriptase inhibitors. Antimicrob. Agents Chemother., 2007, 51, 429-437.
12. Wu, J.; Liu, X.; Cheng, X.; Cao, Y.; Wang, D.; Li, Z.; Xu, W.; Pannecouque, C.; Witvrouw, M.; De Clercq, E. Synthesis of novel derivatives of 4-amino-3-(2-furyl)-5-mercapto-1,2,4-triazole as potential HIV-1 NNRTIs. Molecules, 2007, 12, 2003-2016.
13. Zhan, P.; Liu, X.; Li, Z.; Fang, Z.; Wang, D.; Pannecouque, C.; Clercq, E. D. Novel 1,2,3-thiadiazole derivatives as HIV-1 NNRTIs with improved potency: Synthesis and preliminary SAR studies. Bioorg. Med. Chem., 2009, 17, 5920-5927.
14. Zhan, P.; Liu, X. Y.; Li, Z. Y.; Fang, Z. J.; Pannecouque, C.; De Clercq, E. 1,2,3-thiadiazole thioacetanilides. Part 2: Synthesis and biological evaluation of a new series of 2-{[4-(3,4-dichlorophenyl)- 1,2,3-thiadiazol-5-yl] sulfanyl}acetanilides as HIV-1 inhibitors. Chem. Biodivers., 2010, 7, 1717-1727.
15. Zhan, P.; Chen, X.; Li, X.; Li, D.; Tian, Y.; Chen, W.; Pannecouque, C.; De Clercq, E.; Liu, X. Arylazolylthioacetanilide. Part 8: Design, synthesis and biological evaluation of novel 2-(2- (2,4-dichlorophenyl)-2H-1,2,4-triazol-3- ylthio)-N-arylacetamides as potent HIV-1 inhibitors. Eur. J. Med. Chem., 2011, 46, 5039-5045.
16. Nadkarni, B. A.; Kamat, V. R.; Khadse, B. G. Synthesis and anthelmintic activity of 3,6-disubstituted-7H-s-triazolo(3,4- b)(1,3,4)thiadiazines. Arzneim. forsch., 2001, 51, 569-573.
17. Shivarama Holla, B.; Veerendra, B.; Shivananda, M. K.; Poojary, B. Synthesis characterization and anticancer activity studies on some Mannich bases derived from 1,2,4-triazoles. Eur. J. Med. Chem., 2003, 38, 759-767.
18. Sarva, M. C.; Romeo, G.; Guerrera, F.; Siracusa, M.; Salerno, L.; Russo, F.; Cagnotto, A.; Goegan, M.; Mennini, T. [1,2,4]Triazole derivatives as 5-HT(1A) serotonin receptor ligands. Bioorg. Med. Chem., 2002, 10, 313-323.
19. Collin, X.; Sauleau, A.; Coulon, J. 1,2,4-Triazolo mercapto and aminonitriles as potent antifungal agents. Bioorg. Med. Chem. Lett., 2003, 13, 2601-2605.